CD274 and cancer: Moreover, recent studies also indicate that 2DG may indirectly improve anti-tumor immunity by increasing immunogenic cell death in combination with chemotherapy [34] and reducing the glycosylation and surface expression of inhibitory immune checkpoints PD-L1 [38,39,40] and PD-1 [40,41,42] on cancer cells and T cells, respectively.